215 related articles for article (PubMed ID: 37175922)
1. The Landscape of Aberrant Alternative Splicing Events in Steatotic Liver Graft Post Transplantation via Transcriptome-Wide Analysis.
Liu H; Zhu Y; Ng KT; Lo CM; Man K
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175922
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome-Wide Analysis Reveals the Landscape of Aberrant Alternative Splicing Events in Liver Cancer.
Li S; Hu Z; Zhao Y; Huang S; He X
Hepatology; 2019 Jan; 69(1):359-375. PubMed ID: 30014619
[TBL] [Abstract][Full Text] [Related]
3. Arachidonic acid activates NLRP3 inflammasome in MDSCs via FATP2 to promote post-transplant tumour recurrence in steatotic liver grafts.
Liu H; Yeung WHO; Pang L; Liu J; Liu XB; Pan Ng KT; Zhang Q; Qiu WQ; Zhu Y; Ding T; Wang Z; Zhu JY; Lo CM; Man K
JHEP Rep; 2023 Dec; 5(12):100895. PubMed ID: 37916155
[TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma.
Huang R; Yan G; Sun H; Zhang J; Song D; Kong R; Yan P; Hu P; Xie A; Wang S; Zhuang J; Yin H; Meng T; Huang Z
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32627826
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Liver Graft Injury on Cancer Recurrence Posttransplantation.
Li CX; Man K; Lo CM
Transplantation; 2017 Nov; 101(11):2665-2670. PubMed ID: 28665890
[TBL] [Abstract][Full Text] [Related]
6. Effect of steatosis donor liver transplantation on hepatocellular carcinoma recurrence: experience at a single institution.
Teng da H; Zhu ZJ; Zheng H; Deng YL; Sun LY; Pan C; Liu YH; Song HL; Shen ZY
Hepatogastroenterology; 2012 May; 59(115):858-62. PubMed ID: 22389257
[TBL] [Abstract][Full Text] [Related]
7. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
Wang XQ; Luk JM; Leung PP; Wong BW; Stanbridge EJ; Fan ST
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):483-9. PubMed ID: 15701831
[TBL] [Abstract][Full Text] [Related]
8. Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells.
Mikuriya Y; Tashiro H; Kuroda S; Nambu J; Kobayashi T; Amano H; Tanaka Y; Ohdan H
Int J Cancer; 2015 Feb; 136(4):E3-13. PubMed ID: 25053237
[TBL] [Abstract][Full Text] [Related]
9. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
[TBL] [Abstract][Full Text] [Related]
10. Alternative splicing events are prognostic in hepatocellular carcinoma.
Chen QF; Li W; Wu P; Shen L; Huang ZL
Aging (Albany NY); 2019 Jul; 11(13):4720-4735. PubMed ID: 31301224
[TBL] [Abstract][Full Text] [Related]
11. Compromised AMPK-PGCIα Axis Exacerbated Steatotic Graft Injury by Dysregulating Mitochondrial Homeostasis in Living Donor Liver Transplantation.
Liu J; Pang L; Ng KTP; Chiu TLS; Liu H; Liu X; Xu A; Lo CM; Man K
Ann Surg; 2022 Nov; 276(5):e483-e492. PubMed ID: 32889872
[TBL] [Abstract][Full Text] [Related]
12. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Gene Expression Profiles Differentiate Steatotic and Non-steatotic Grafts in Liver Transplant Recipients.
Šeda O; Cahová M; Míková I; Šedová L; Daňková H; Heczková M; Brátová M; Ďásková N; Erhartová D; Čapek V; Chylíková B; Trunečka P
Front Endocrinol (Lausanne); 2019; 10():270. PubMed ID: 31114547
[No Abstract] [Full Text] [Related]
14. Transcriptome Analysis of Acute Phase Liver Graft Injury in Liver Transplantation.
Lee NP; Wu H; Ng KTP; Luo R; Lam TW; Lo CM; Man K
Biomedicines; 2018 Apr; 6(2):. PubMed ID: 29642405
[TBL] [Abstract][Full Text] [Related]
15. FGF15 improves outcomes after brain dead donor liver transplantation with steatotic and non-steatotic grafts in rats.
Gulfo J; Rotondo F; Ávalos de León CG; Cornide-Petronio ME; Fuster C; Gracia-Sancho J; Jiménez-Castro MB; Peralta C
J Hepatol; 2020 Nov; 73(5):1131-1143. PubMed ID: 32422221
[TBL] [Abstract][Full Text] [Related]
16. Post-transplant endothelial progenitor cell mobilization via CXCL10/CXCR3 signaling promotes liver tumor growth.
Ling CC; Ng KT; Shao Y; Geng W; Xiao JW; Liu H; Li CX; Liu XB; Ma YY; Yeung WH; Qi X; Yu J; Wong N; Zhai Y; Chan SC; Poon RT; Lo CM; Man K
J Hepatol; 2014 Jan; 60(1):103-9. PubMed ID: 23994383
[TBL] [Abstract][Full Text] [Related]
17. Postperfusion energy metabolism of steatotic graft and its relation to early graft viability following liver transplantation.
Miki C; Iriyama K; Mirza DF; Mayer AD; Buckels JA; Suzuki H; McMaster P
Dig Dis Sci; 1998 Jan; 43(1):74-9. PubMed ID: 9508538
[TBL] [Abstract][Full Text] [Related]
18. Identification of alternative splicing events related to fatty liver formation in duck using full-length transcripts.
Wang Y; Song L; Ning M; Hu J; Cai H; Song W; Gong D; Liu L; Smith J; Li H; Huang Y
BMC Genomics; 2023 Mar; 24(1):92. PubMed ID: 36858953
[TBL] [Abstract][Full Text] [Related]
19. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
20. Melatonin protects steatotic and nonsteatotic liver grafts against cold ischemia and reperfusion injury.
Zaoualí MA; Reiter RJ; Padrissa-Altés S; Boncompagni E; García JJ; Ben Abnennebi H; Freitas I; García-Gil FA; Rosello-Catafau J
J Pineal Res; 2011 Mar; 50(2):213-21. PubMed ID: 21108657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
